Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
Home
ETF
KYTX
KYTX
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
KYTX News
Kyverna Therapeutics Plans to Raise $300M in Securities Offering
4d ago
seekingalpha
Kyverna Therapeutics Q4 Earnings Beat Expectations
4d ago
seekingalpha
Kyverna Presents New Therapies at Neurology Annual Meeting
Mar 05 2026
Newsfilter
Biotech Stocks Surge in 2025 with $30.9 Billion M&A Wave
Dec 31 2025
Benzinga
Biohaven Ltd's Depression Drug Trial Fails to Meet Primary Endpoint, Shares Plunge 14.3%
Dec 26 2025
Benzinga
Weekly Update: CYTK Receives Initial FDA Approval, INSM Concludes Rhinosinusitis Research, XOMA Purchases GBIO
Dec 20 2025
NASDAQ.COM
Crude Oil Increases by More Than 1%; General Mills Reports Earnings Exceeding Expectations
Dec 17 2025
Benzinga
Kyverna Therapeutics Prices 13.33M Shares at $7.50, Raising Approximately $100M
Dec 17 2025
Newsfilter
Dow Rises by 150 Points as Jabil Reports Positive Earnings
Dec 17 2025
Benzinga
Aditxt Shares Surge Approximately 63%; Check Out 20 Stocks Making Moves in Premarket Trading
Dec 17 2025
Benzinga
Lightwave Logic, Kyverna Therapeutics, and Other Major Stocks Decline in Tuesday's Pre-Market Trading
Dec 16 2025
Benzinga
Kyverna Therapeutics Launches $100 Million Underwritten Public Offering to Fund Cell Therapy Development
Dec 15 2025
Globenewswire
Kyverna Therapeutics Launches $100 Million Public Offering with $15 Million Underwriter Option
Dec 15 2025
Newsfilter
Kyverna Stock Soars 27% Following Encouraging Topline Results from CAR-T Autoimmune Research
Dec 15 2025
NASDAQ.COM
Crude Oil Declines by More Than 1%; US Homebuilder Confidence Rises Slightly in December
Dec 15 2025
Benzinga
Kyverna Therapeutics Plans $100M Public Offering
Dec 15 2025
SeekingAlpha
Show More News
